Targeted lateral pelvic lymph node excision in the setting of total neoadjuvant therapy for rectal cancer.
Journal
ANZ journal of surgery
ISSN: 1445-2197
Titre abrégé: ANZ J Surg
Pays: Australia
ID NLM: 101086634
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
received:
06
10
2022
accepted:
28
10
2022
pubmed:
19
11
2022
medline:
22
3
2023
entrez:
18
11
2022
Statut:
ppublish
Résumé
Targeted lateral pelvic node dissection in the era of total neoadjuvant therapy.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
680-681Informations de copyright
© 2022 The Authors. ANZ Journal of Surgery published by John Wiley & Sons Australia, Ltd on behalf of Royal Australasian College of Surgeons.
Références
Ueno H, Mochizuki H, Hashiguchi Y, Hase K. Prognostic determinants of patients with lateral nodal involvement by rectal cancer. Ann. Surg. 2001; 234: 190-7.
Shib OC, Taylor F, Bees N, Blake H et al. Relevance of magnetic resonance imaging-detected pelvic sidewall lymph node involvement in rectal cancer. Br. J. Surg. 2011; 98: 1798-804.
Ueno H, Mochizyki H, Hashiguchi Y, Ishiguro M et al. Potential prognostic benefit of lateral pelvic node dissection for rectal cancer located below the peritoneal reflection. Ann. Surg. 2007; 245: 80-7.
Ogura A, Konishi T, Cunningham C et al. Neoadjuvant (chemo)radiotherapy with total mesorectal excision only is not sufficient to prevent lateral local recurrence in enlarged nodes: results of the multicenter lateral node study of patients with low cT3/4 rectal cancer. J. Clin. Oncol. 2019; 37: 33-43.
Kim MJ, Kim TH, Kim DY et al. Can chemoradiation allow for omission of lateral pelvic node dissection for locally advanced rectal cancer? J. Surg. Oncol. 2015; 111: 459-64.
Kim MJ, Park SC, Kim TH, Kim DY et al. Is lateral pelvic node dissection necessary after preoperative chemoradiotherapy for rectalcancer patients with initially suspected lateral pelvic node? Surgery 2016; 160: 366-76.